Stay updated on Safety & Efficacy of SHP465 in Adults with ADHD Clinical Trial
Sign up to get notified when there's something new on the Safety & Efficacy of SHP465 in Adults with ADHD Clinical Trial page.

Latest updates to the Safety & Efficacy of SHP465 in Adults with ADHD Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedAdded a consolidated, state-by-state list of study locations (California, Colorado, Florida, Georgia, Illinois, Kansas, Louisiana, Michigan, Missouri, Nebraska, Nevada, New Jersey, New York, North Carolina, Ohio, Oklahoma, Oregon, Rhode Island, South Carolina, Tennessee, Texas, Virginia, and Washington) and updated the record to revision v3.3.3. The per-state location subsections (e.g., California Locations, Colorado Locations) were removed in this update.SummaryDifference2%

- Check41 days agoChange DetectedPage revision updated from v3.3.1 to v3.3.2 with no substantive changes to study details or navigation. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check55 days agoChange DetectedPublications section updated to clarify automatic PubMed population and potential irrelevance to the study, with revision changed to v3.3.1. The previous wording suggesting automatic creation tied to the NCT number (v3.2.0) was removed.SummaryDifference0.1%

- Check63 days agoChange DetectedRemoved the banner containing the government funding and NIH operating status notice from the page; this does not affect the study details or eligibility criteria. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check77 days agoChange DetectedNo significant additions or deletions were detected; the page content and details appear unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check106 days agoChange Detected- Added a prominent notice about potential outages due to lapse in government funding and updated operating status guidance. - Updated version from v3.1.0 to v3.2.0.SummaryDifference4%

Stay in the know with updates to Safety & Efficacy of SHP465 in Adults with ADHD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety & Efficacy of SHP465 in Adults with ADHD Clinical Trial page.